Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.
Bousvaros
A
A
Combined Program in Gastroenterology and Nutrition, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Sundel
R
R
Thorne
G M
GM
McIntosh
K
K
Cohen
M
M
Erdman
D D
DD
Perez-Atayde
A
A
Finkel
T H
TH
Colin
A A
AA
D002648:Child; D018549:Cryptogenic Organizing Pneumonia / Q000175:diagnosis / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D006525:Hepatitis, Viral, Human / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000188:drug therapy; D009220:Myositis / Q000175:diagnosis* / Q000188:drug therapy; D010322:Parvoviridae Infections / Q000175:diagnosis* / Q000188:drug therapy; D016732:Parvovirus B19, Human
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide